We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$8.61B
AUM Growth
-$1.19B
Cap. Flow
-$1.6B
Cap. Flow %
-18.6%
Top 10 Hldgs %
25.39%
Holding
1,443
New
297
Increased
221
Reduced
85
Closed
241

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$458M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$47.5M
3
HDB icon
HDFC Bank
HDB
+$47.1M
4
CSCO icon
Cisco
CSCO
+$44.8M
5
T icon
AT&T
T
+$43.6M

Sector Composition

Rank Sector Weight
1 Technology 15.01%
2 Financials 13.41%
3 Consumer Discretionary 4.2%
4 Healthcare 3.9%
5 Communication Services 3.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSRXW
1076
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$221K ﹤0.01%
22,650
SMIHU
1077
DELISTED
Summit Healthcare Acquisition Corp. Units
SMIHU
$219K ﹤0.01%
22,360
+3,800
+20% +$37.6K
UTI icon
1078
Universal Technical Institute
UTI
$2.12B
$216K ﹤0.01%
+24,365
New +$200K
ZION icon
1079
Zions Bancorporation
ZION
$10B
$216K ﹤0.01%
+3,293
New +$225K
CRC icon
1080
California Resources
CRC
$4.51B
$209K ﹤0.01%
+4,675
New +$202K
CYBE
1081
DELISTED
Cyberoptics Corp
CYBE
$209K ﹤0.01%
+5,150
New +$198K
AVIR icon
1082
Atea Pharmaceuticals
AVIR
$386M
$207K ﹤0.01%
+28,671
New +$195K
QUAD icon
1083
Quad
QUAD
$438M
$207K ﹤0.01%
+29,809
New +$156K
HCIIW
1084
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$206K ﹤0.01%
21,047
ALCO icon
1085
Alico
ALCO
$286M
$205K ﹤0.01%
+5,468
New +$190K
FFIV icon
1086
F5
FFIV
$23B
$205K ﹤0.01%
+983
New +$206K
VINC
1087
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$205K ﹤0.01%
+2,560
New +$316K
LGACW
1088
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$196K ﹤0.01%
20,000
WPCB.WS
1089
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
$196K ﹤0.01%
20,000
VEEAW
1090
Veea Inc Warrant
VEEAW
$756K
$195K ﹤0.01%
20,000
VIGL
1091
DELISTED
Vigil Neuroscience
VIGL
$194K ﹤0.01%
+27,642
New +$365K
ONDS icon
1092
Ondas Inc
ONDS
$4.57B
$193K ﹤0.01%
+26,411
New +$141K
USER
1093
DELISTED
UserTesting, Inc.
USER
$193K ﹤0.01%
18,090
-31,910
-64% -$265K
SST icon
1094
System1
SST
$15.7M
$191K ﹤0.01%
+1,316
New +$162K
TNGX icon
1095
Tango Therapeutics
TNGX
$4.35B
$190K ﹤0.01%
25,000
-13,459
-35% -$117K
VYGR icon
1096
Voyager Therapeutics
VYGR
$187M
$189K ﹤0.01%
+24,740
New +$110K
ATIP
1097
DELISTED
ATI Physical Therapy, Inc.
ATIP
$189K ﹤0.01%
2,014
HCIC
1098
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$188K ﹤0.01%
19,171
VIEWW
1099
DELISTED
View, Inc. Warrant
VIEWW
$184K ﹤0.01%
100,000
FRONW
1100
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
$183K ﹤0.01%
18,750

Similar funds

LMR Partners's Q1 2022 Portfolio in Review

As of Q1 2022, LMR Partners held 1,443 positions worth $8.61B, down 12% from $9.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

LMR Partners withdrew a net $1.6B in Q1 2022, closing 241 positions and reducing 85 holdings. Its most notable exit was Xilinx Inc, an estimated $135M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 9.2% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, LMR Partners opened a new position in Cisco worth $44.1M.

  • LMR Partners's largest Q1 2022 buy was Cisco: 791,655 shares worth $44.1M.
  • LMR Partners added most to TSMC in Q1 2022, an estimated $458M increase.
  • LMR Partners's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $942M.
  • LMR Partners fully exited Xilinx Inc in Q1 2022, selling an estimated $135M.
  • LMR Partners's ten largest holdings make up 25% of its $8.61B portfolio in Q1 2022.
  • LMR Partners opened 297 new positions and closed 241 in Q1 2022.
  • LMR Partners's portfolio value fell 12% quarter-over-quarter to $8.61B.

Based on LMR Partners's 13F filing for Q1 2022, filed 16 May 2022.